Prellis Biologics

Integrating human biology with machine learning for antibody discovery

[Prellis Biologics @Prellisbio]

We have partnered with Eli Lilly in a multi-target antibody discovery and development collaboration. This milestone marks one of the first external uses of our Bio AI platform.

Leanr more about this collaboration:
https://t.co/vCRv7zWchP

#biotech #lifesciences #bioai

[Prellis Biologics @Prellisbio]

We’ve partnered with Eli Lilly and Co. in a multi-target antibody discovery and development collaboration.

This milestone marks one of the first external uses of our Bio AI platform.

Read more here:
https://t.co/vCRv7zWchP

[Prellis Biologics @Prellisbio]

Prellis Biologics has partnered with @EliLillyandCo in a multi-target antibody discovery and development collaboration.

This milestone marks one of the first external uses of our Bio AI platform.

Learn more:
https://t.co/vCRv7zWchP

#lifesciences #bioai

[Prellis Biologics @Prellisbio]

Prellis Biologics has partnered with @EliLillyandCo in a multi-target antibody discovery & development collaboration.

This milestone marks one of the first external uses of our Bio AI platform.

Read more from our press release:
https://t.co/vCRv7zWchP

#biotech #bioai

[Prellis Biologics @Prellisbio]

We’ve partnered with @EliLillyandCo in a multi-target antibody discovery and development collaboration. This milestone marks one of the first external uses of our Bio AI platform.

Read the release:

https://t.co/vCRv7zWK7n

#biotech #lifesciences #bioai

[Prellis Biologics @Prellisbio]

We’ve partnered with @EliLillyandCo in a multi-target antibody discovery and development collaboration. This milestone marks one of the first external uses of our Bio AI platform.

Read more here:
https://t.co/vCRv7zWchP

#biotech #lifesciences #bioai

[Prellis Biologics @Prellisbio]

We're thrilled to announce the launch of our new website, unveiling our groundbreaking EXIS™ platform for antibody discovery!

Head over to our new website at https://t.co/KwvUvLgu0b to explore the science behind our cutting-edge platform! #Biotechnology #AntibodyDiscovery #AI

[Prellis Biologics @Prellisbio]

Prellis is pioneering the new path to fully human antibody discovery, immunogenicity, and vaccine screening. Connect with our leadership team at #BIO2022.
https://t.co/b44ICSws0M

[Prellis Biologics @Prellisbio]

Unprecedented access to the human immune system with the Externalized Immune System (EXIS) platform. Meet with the Prellis Bio team at @BIOConvention via the BIO partnering system. #BIO2022
https://t.co/b44ICSws0M

[Prellis Biologics @Prellisbio]

Prellis is bringing the human immune system into the lab with our Externalized Immune System (EXIS™) platform.

Learn more at https://t.co/jsC2521rLj.

[Melanie Matheu, PhD @melanie_matheu]

While I applaud the efforts in silico to solve problems in drug discovery, no system does it better than the immune system: we make our own drugs. Access to human immunobiology is a direct line to therapeutics, and distinctly advantageous starting point for in silico platforms.

[Prellis Biologics @Prellisbio]

In recognition of #WomensHistoryMonth, we’re celebrating the powerful contributions of #WomenInSTEM, including the achievements of the women at Prellis. Learn about our team's expertise in #AntibodyDiscovery and #TissueEngineering at https://t.co/jjCwpUrkXH.

[Prellis Biologics @Prellisbio]

A deep dive with our founder @melanie_matheu where she discusses her background, inspiration, and what it takes to be a company founder.

[Celesta Capital @CelestaCapital]

Celesta Capital Founder Spotlight: @melanie_matheu, founder & CEO of @Prellisbio, shares her path to entrepreneurship, and how she seeks inspiration: https://t.co/BCBQ2GZfBt

[Prellis Biologics @Prellisbio]

Sanofi CEO Paul Hudson continues hunt for new tech, spearing a deal with organoid startup - https://t.co/YfHxvEbnmG

[Prellis Biologics @Prellisbio]

PrellisBio is delighted to announce a human antibody discovery collaboration with @sanofi using our #EXIS platform.

https://t.co/vlf9W44Xgb

[Prellis Biologics @Prellisbio]

We are looking forward to #BioEurope Spring 2022!

Connect with us for a virtual meeting via the PartneringONE platform to learn more about our Externalized Immune System (EXIS™) platform for #AntibodyDiscovery and #Immunogenicity testing.

https://t.co/jjCwpUrkXH

[Melanie Matheu, PhD @melanie_matheu]

Had a fantastic time with the @cantos team discussing our human #antibody platform derived from first in class lymph node organoids — and how application of our holographic laser printing has opened the door to a multitude of human tissue applications/products.

[Prellis Biologics @Prellisbio]

@JenniferGrinder Feel free to send us an email [email protected]

[Prellis Biologics @Prellisbio]

Another day in the lab doing #AntibodyDiscovery and #immunogenicity testing with the Prellis bio team.

https://t.co/o91AeAtGaj #Biotech #STEM #Antibody #Antibodies #ImmuneSystem

[Prellis Biologics @Prellisbio]

Join us this Friday at 12pm PT for Dr. David Schaffer's #TissueEngineering Journal Club #webinar presentation, "Molecular Elucidation and #Engineering of #StemCell Fate Decisions."

Register at https://t.co/rMavQO0PCZ.

#Biotech #STEM #Seminar @QB3Berkeley @UCBerkeley

[Prellis Biologics @Prellisbio]

Next week, Prellis is hosting Dr. David Schaffer, Professor at @UCBerkeley, at our TEJC #webinar. Join us for his presentation, "Molecular Elucidation and #Engineering of #StemCell Fate Decisions."

Register at https://t.co/rMavQO0PCZ.

#Biotech #TissueEngineering